|
| 1 | Hydroquinone 4%+ tretinoin 0.05% +Fluocinolone 0.01 % skin cream, 15 gm |
| 2 | Povidone iodine Solution 5%, 500 ml |
| 3 | Povidone iodine Ointment 5%,15 gm |
| 4 | Furosemide Tablet 40 mg |
| 5 | Spironolactone Tablet 25 mg |
| 6 | Tamsulosin 0.4 mg + Dutasteride 0.5 mg Tablet |
| 7 | Disodium Hydrogen Citrate Oral solution/syrup 1.38 -1.45 gm/ 5 ml, 100 ml bottle |
| 8 | Aluminium hydroxide 240 mg + Magnesium hydroxide 100 mg + Simethicone 25 mg + Magnesium carbonate 60 mg Chewable Tablet |
| 9 | Omeprazole Capsule 20 mg |
| 10 | Pantoprazole + Domperidone SR (40 mg + 30 mg) Capsule |
| 11 | Simethicone Syrup 40 mg, 60 ml Bottle |
| 12 | Domperidone Suspension 1 mg/ml, 30 ml bottle |
| 13 | Cinnarizine Tablet 25 mg |
| 14 | Ondansetron Tablet 8 mg |
| 15 | Anti-Haemorrhoidal Containing: Beclomethasone Dipropionate 0.025% w/w, Phenylephrine Hyderochloride 0.10% w/w, Lignocaine Hydrochloride 2.5% w/w in soft paraffin base 20 gm tube |
| 16 | Dicyclomine Oral solution 10 mg / 5 ml |
| 17 | Enema |
| 18 | Oral Rehydration salts Powder for 1000 ml solution |
| 19 | Oral rehydration salts Powder for 200 ml solution |
| 20 | Saccharomyces boulardii 5 CFU sachets |
| 21 | Metformin Tablet 1 gm |
| 22 | Glimipride Tablet 1 mg |
| 23 | Glimipride Tablet 2 mg |
| 24 | Voglibose 0.3 mg + Metformin 500 mg + Glimipride 1 mg Tablet |
| 25 | Medroxyprogesterone Tablet 10 mg |
| 26 | Norethisterone Tablet 5 mg |
| 27 | Micronized Progesterone Tablet 200 mg |
| 28 | Cabergoline Tablet 0.5 mg |
| 29 | Thyroxine Tablet 50 mcg |
| 30 | Carbimazole Tablet 5 mg |
| 31 | Ethinyestradiol Tablet 5 mcg |
| 32 | Acyclovir Eye Ointment 5%, 5 gm |
| 33 | Olopatadine 0.1% Eye Drops 5 ml |
| 34 | Acetazolamide Tablet 250 mg |
| 35 | Homatropine Eye Drops 1% |
| 36 | Tropicamide + Phenylepherine Eye Drops 0.8% + 5%, 5 ml vial |
| 37 | Cyclopentolate Eye Drops 1% w/v Albendazole Chewable tablets 400 mg(The Chewable tablets shall also comply with the test for disintegration and dissolution as per monograph given in International pharmacopeia as per requirement of GOI) Please Enable Macros to View BoQ information |
